tiprankstipranks
Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
US Market
Holding NAUT?
Track your performance easily

Nautilus Biotechnolgy (NAUT) Income Statement

122 Followers

Nautilus Biotechnolgy Income Statement

Last quarter (Q3 2024), Nautilus Biotechnolgy's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Nautilus Biotechnolgy's net income was $-16.45M. See Nautilus Biotechnolgy’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Mar 23Dec 22Dec 21
Total Revenue
--$ 286.77M--
Cost of Revenue
--$ 234.82M--
Gross Profit
--$ 51.95M--
Operating Expense
$ 78.97M$ 76.15M$ 145.31M$ 63.62M$ 50.50M
Operating Income
$ -78.97M$ -76.15M$ -93.36M$ -63.62M$ -50.50M
Net Non Operating Interest Income Expense
$ 11.70M$ 12.55M$ -3.79M$ 5.82M$ 329.00K
Other Income Expense
$ -51.00K$ -73.00K$ 982.00K$ -122.00K$ 146.00K
Pretax Income
$ -67.36M$ -63.67M$ -98.13M$ -57.92M$ -50.31M
Tax Provision
$ -4.03M$ -4.03M$ 9.36M$ -3.13M$ -3.04M
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -67.36M$ -63.67M$ -105.44M$ -57.92M$ -50.31M
Basic EPS
$ -0.53$ -0.51$ -3.34$ -0.46$ -0.60
Diluted EPS
$ -0.53$ -0.51$ -3.34$ -0.46$ -0.60
Basic Average Shares
$ 501.25M$ 124.92M$ 31.59M$ 124.59M$ 84.46M
Diluted Average Shares
$ 501.25M$ 124.92M$ 31.59M$ 124.59M$ 84.46M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 78.97M$ 76.15M$ 380.13M$ 63.62M$ 50.50M
Net Income From Continuing And Discontinued Operation
$ -67.36M$ -63.67M$ -105.40M$ -57.92M$ -50.31M
Normalized Income
$ -34.11M---$ -53.36M
Interest Expense
-----
EBIT
$ -70.33M$ -76.15M$ -94.33M$ -63.62M$ -50.31M
EBITDA
$ -63.30M$ -70.45M$ -83.23M$ -60.20M$ -47.31M
Currency in USD

Nautilus Biotechnolgy Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis